Directly related to the hepatitis B virus — infection status, viral activity, and immune response.
Enzymes and proteins that show whether the liver is inflamed, damaged, or struggling to perform its functions.
Cell counts and kidney markers — key for detecting complications and monitoring antiviral drug safety.
Liver cancer screening, thyroid function, and metabolic markers that influence HBV outcomes.
FibroScan (Transient Elastography) measures liver stiffness in kilopascals (kPa) to estimate fibrosis, and the CAP score in dB/m to estimate liver fat. Enter your results below. For accurate interpretation, always note the probe type and your ALT level at the time of testing.
Reference ranges and interpretations for this test are based on the following authoritative guidelines:
HepB Lab Compass is an educational tool to help people with hepatitis B understand their laboratory results in plain language.
This tool does not provide medical advice, diagnosis, or treatment recommendations. Interpretations are based on published international guidelines and are generalised — they cannot account for your individual clinical situation.
Reference ranges may vary between laboratories. Always compare your results with your laboratory's own reference range, and discuss every result with your hepatologist or treating physician before making any health decisions.
Guideline sources: EASL 2025 HBV CPG, AASLD/IDSA 2025, WHO 2024, EASL 2021 Non-Invasive Tests CPG, Baveno VII (2022), REVEAL-HBV study.